Roche To Invest $135 Million Into Two New Manufacturing Facilities
Swiss drugmaker Roche said on Monday it would invest 120 million Swiss francs ($135 million) in two new manufacturing facilities at its Basel headquarters, bucking a trend of cost-cutting by other big pharmaceutical companies. The world's largest maker of cancer drugs plans to spend 85 million francs on a new facility for chemically manufactured medicines, which is expected to enter operation at the start of the third quarter of 2016. It will also invest 35 million francs on expanding and refitting an existing manufacturing unit to produce investigational drugs and medicines that are already on the market.
Help employers find you! Check out all the jobs and post your resume.